Could a popular weight loss drug help beat rectal cancer?
Disease control
Not yet recruiting
This study is testing if adding a weight loss medication (a GLP-1 receptor agonist like semaglutide) to standard pre-surgery cancer treatment improves results for overweight patients with locally advanced rectal cancer. Researchers will compare two groups: one gets the standard t…
Phase: PHASE2 • Sponsor: St. James's Hospital, Ireland • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC